iBio, Inc. Common Stock (IBIO)

iBio, Inc. Common Stock (IBIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $72.3M; returns 1 day -8.4%, 1 week -6.3%, 1 year -43.5%.

iBio, Inc. (IBIO) is a preclinical-stage biotechnology company that leverages Artificial Intelligence (AI) and advanced computational biology to discover and develop precision antibody therapies.

Groups IBIO belongs to

• Biotechnology
• Clinical Stage Biotech
• Preclinical Development
• Antibody Therapeutics
• Artificial Intelligence
• Metabolic Disorders
• Weight Management
• AI in Healthcare
• GLP-1 Agonists
• Drug Discovery
• Precision Medicine

IBIO financial model: income statement, cash flow and balance sheet